cbdMD (YCBD) Current Deferred Revenue (2017 - 2025)

cbdMD has disclosed Current Deferred Revenue across 8 years of filings, most recently posting $488626.0 for Q4 2025.

• Current Deferred Revenue for Q4 2025 came in at $488626.0, down 7.36% year-over-year; the trailing twelve-month figure through Dec 2025 was $488626.0 (down 7.36% YoY), and the FY2025 annual result was $506289.0, up 0.6% from the prior year.
• Current Deferred Revenue came in at $488626.0 for Q4 2025 at cbdMD, down from $506289.0 in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $557353.0 in Q1 2025 to a low of $755.0 in Q2 2021.
• The 4-year median for Current Deferred Revenue is $504771.5 (2024), against an average of $429667.4.
• Across the five-year window, Current Deferred Revenue surged 171.67% in 2024 and dropped 7.43% in 2025, its largest moves.
• cbdMD's Current Deferred Revenue stood at $755.0 in 2021, then surged by 24435.89% to $185246.0 in 2023, then surged by 184.72% to $527438.0 in 2024, then declined by 7.36% to $488626.0 in 2025.
• The last three Current Deferred Revenue figures came in at $488626.0 (Q4 2025), $506289.0 (Q3 2025), and $509198.0 (Q2 2025), per Business Quant data.